BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27165366)

  • 1. Neuroblastoma and Its Zebrafish Model.
    Zhu S; Thomas Look A
    Adv Exp Med Biol; 2016; 916():451-78. PubMed ID: 27165366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated ALK collaborates with MYCN in neuroblastoma pathogenesis.
    Zhu S; Lee JS; Guo F; Shin J; Perez-Atayde AR; Kutok JL; Rodig SJ; Neuberg DS; Helman D; Feng H; Stewart RA; Wang W; George RE; Kanki JP; Look AT
    Cancer Cell; 2012 Mar; 21(3):362-73. PubMed ID: 22439933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferation and Survival of Embryonic Sympathetic Neuroblasts by MYCN and Activated ALK Signaling.
    Kramer M; Ribeiro D; Arsenian-Henriksson M; Deller T; Rohrer H
    J Neurosci; 2016 Oct; 36(40):10425-10439. PubMed ID: 27707976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells.
    Schönherr C; Ruuth K; Kamaraj S; Wang CL; Yang HL; Combaret V; Djos A; Martinsson T; Christensen JG; Palmer RH; Hallberg B
    Oncogene; 2012 Dec; 31(50):5193-200. PubMed ID: 22286764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical Role for GAB2 in Neuroblastoma Pathogenesis through the Promotion of SHP2/MYCN Cooperation.
    Zhang X; Dong Z; Zhang C; Ung CY; He S; Tao T; Oliveira AM; Meves A; Ji B; Look AT; Li H; Neel BG; Zhu S
    Cell Rep; 2017 Mar; 18(12):2932-2942. PubMed ID: 28329685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma.
    Cazes A; Lopez-Delisle L; Tsarovina K; Pierre-Eugène C; De Preter K; Peuchmaur M; Nicolas A; Provost C; Louis-Brennetot C; Daveau R; Kumps C; Cascone I; Schleiermacher G; Prignon A; Speleman F; Rohrer H; Delattre O; Janoueix-Lerosey I
    Oncotarget; 2014 May; 5(9):2688-702. PubMed ID: 24811913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studying the peripheral sympathetic nervous system and neuroblastoma in zebrafish.
    Morrison MA; Zimmerman MW; Look AT; Stewart RA
    Methods Cell Biol; 2016; 134():97-138. PubMed ID: 27312492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated ALK signals through the ERK-ETV5-RET pathway to drive neuroblastoma oncogenesis.
    Lopez-Delisle L; Pierre-Eugène C; Louis-Brennetot C; Surdez D; Raynal V; Baulande S; Boeva V; Grossetête-Lalami S; Combaret V; Peuchmaur M; Delattre O; Janoueix-Lerosey I
    Oncogene; 2018 Mar; 37(11):1417-1429. PubMed ID: 29321660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mosaic zebrafish transgenesis for functional genomic analysis of candidate cooperative genes in tumor pathogenesis.
    Ung CY; Guo F; Zhang X; Zhu Z; Zhu S
    J Vis Exp; 2015 Mar; (97):. PubMed ID: 25867597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma.
    Berry T; Luther W; Bhatnagar N; Jamin Y; Poon E; Sanda T; Pei D; Sharma B; Vetharoy WR; Hallsworth A; Ahmad Z; Barker K; Moreau L; Webber H; Wang W; Liu Q; Perez-Atayde A; Rodig S; Cheung NK; Raynaud F; Hallberg B; Robinson SP; Gray NS; Pearson AD; Eccles SA; Chesler L; George RE
    Cancer Cell; 2012 Jul; 22(1):117-30. PubMed ID: 22789543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALK(R1275Q) perturbs extracellular matrix, enhances cell invasion and leads to the development of neuroblastoma in cooperation with MYCN.
    Ueda T; Nakata Y; Yamasaki N; Oda H; Sentani K; Kanai A; Onishi N; Ikeda K; Sera Y; Honda ZI; Tanaka K; Sata M; Ogawa S; Yasui W; Saya H; Takita J; Honda H
    Oncogene; 2016 Aug; 35(34):4447-58. PubMed ID: 26829053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroblastoma models for insights into tumorigenesis and new therapies.
    Kiyonari S; Kadomatsu K
    Expert Opin Drug Discov; 2015 Jan; 10(1):53-62. PubMed ID: 25345447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of conditional ALK F1174L mutant mouse models for the study of neuroblastoma pathogenesis.
    Ono S; Saito T; Terui K; Yoshida H; Enomoto H
    Genesis; 2019 Oct; 57(10):e23323. PubMed ID: 31218818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells.
    Schulte JH; Lindner S; Bohrer A; Maurer J; De Preter K; Lefever S; Heukamp L; Schulte S; Molenaar J; Versteeg R; Thor T; Künkele A; Vandesompele J; Speleman F; Schorle H; Eggert A; Schramm A
    Oncogene; 2013 Feb; 32(8):1059-65. PubMed ID: 22484425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LMO1 Synergizes with MYCN to Promote Neuroblastoma Initiation and Metastasis.
    Zhu S; Zhang X; Weichert-Leahey N; Dong Z; Zhang C; Lopez G; Tao T; He S; Wood AC; Oldridge D; Ung CY; van Ree JH; Khan A; Salazar BM; Lummertz da Rocha E; Zimmerman MW; Guo F; Cao H; Hou X; Weroha SJ; Perez-Atayde AR; Neuberg DS; Meves A; McNiven MA; van Deursen JM; Li H; Maris JM; Look AT
    Cancer Cell; 2017 Sep; 32(3):310-323.e5. PubMed ID: 28867147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zebrafish as a model to study neuroblastoma development.
    Casey MJ; Stewart RA
    Cell Tissue Res; 2018 May; 372(2):223-232. PubMed ID: 29027617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative NHEJ pathway proteins as components of MYCN oncogenic activity in human neural crest stem cell differentiation: implications for neuroblastoma initiation.
    Newman EA; Chukkapalli S; Bashllari D; Thomas TT; Van Noord RA; Lawlor ER; Hoenerhoff MJ; Opipari AW; Opipari VP
    Cell Death Dis; 2017 Dec; 8(12):3208. PubMed ID: 29238067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pre-rRNA processing factor DEF is rate limiting for the pathogenesis of MYCN-driven neuroblastoma.
    Tao T; Sondalle SB; Shi H; Zhu S; Perez-Atayde AR; Peng J; Baserga SJ; Look AT
    Oncogene; 2017 Jul; 36(27):3852-3867. PubMed ID: 28263972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining Pathological Activities of ALK in Neuroblastoma, a Neural Crest-Derived Cancer.
    Wulf AM; Moreno MM; Paka C; Rampasekova A; Liu KJ
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in PIK3CA are infrequent in neuroblastoma.
    Dam V; Morgan BT; Mazanek P; Hogarty MD
    BMC Cancer; 2006 Jul; 6():177. PubMed ID: 16822308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.